Synta

Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
Winners Of ASCO 2012
Seeking Alpha
Mon, 06/11/12 - 06:19 pm
ASCO
Arqule
Array Biopharma
Astex
AstraZeneca
Bristol-Myers Squibb
GSK
Curis
Exelixis
Pfizer
Immunogen
Seattle Genetics
Sanofi
Synta
Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 3
Seeking Alpha
Mon, 05/28/12 - 11:21 am
ASCO
Synta
Sunesis
Arqule
Cyclacel
Aveo
Bristol-Myers Squibb
Biotech Stocks To Watch In 2012
Seeking Alpha
Mon, 02/6/12 - 11:20 am
Astellas
Array Biopharma
AstraZeneca
Celldex
Exelixis
Pfizer
Progenics Pharmaceuticals
Seattle Genetics
Synta
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
Fri, 08/19/11 - 12:09 pm
OPKO Health
Tengion
GTx
Anadys
Complete Genomics
Amag Pharmaceuticals
MannKind
Threshold Pharmaceuticals
Synta
Genomic Health
Ziopharm
Ardea
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
ASCO
Medivation
Exelixis
Dendreon
Bristol-Myers Squibb
Roche
Curis
Celgene
Sanofi
Ariad Pharmaceuticals
Merck
Incyte
Novartis
YM BioSciences
Pfizer
Aveo Pharmaceutical
ONYX Pharmaceuticals
Amgen
Synta
Vical
Oxigene
Cell Therapeutics
Oncothyreon
Synta's Lead Program Gains Momentum
Seeking Alpha
Sun, 12/5/10 - 12:28 pm
Synta
mTOR inhibitors
STA-9090
cancer
[video] Trading Smallcap Biotech
TheStreet.com
Mon, 02/1/10 - 11:12 am
Savient
Medivation
Prolor
Synta
Chelsea Therapeutics
Halozyme
NeurogesX
Biotech Calendar: Key Dates for December
TheStreet.com
Mon, 11/30/09 - 11:02 am
Exelixis
Dyax
OSI Pharmaceuticals
Isis Pharmaceuticals
Somaxon
Gilead Sciences
Eli Lilly
Vion Pharmaceuticals
Roche
Immunogen
Auxilium
BioDelivery Sciences
Arena Pharmaceuticals
Vivus
Synta
Glaxo pulls out of Synta cancer drug collaboration
Yahoo/AP
Mon, 06/15/09 - 09:24 am
GSK
Synta
cancer
partnerships
Q1 2009 Biotech Roundup: The Good, the Bad and the Ugly
Seeking Alpha
Thu, 04/2/09 - 08:24 am
biotech
Acorda Therapeutics
CV Therapeutics
Arena Pharmaceuticals
Genentech
Gilead Sciences
ZymoGenetics
ViroPharma
MAP Pharmaceuticals
Synta
La Jolla Pharmaceutical
Indevus
InterMune
Osiris Therapeutics
Synta cuts 90 jobs, Glaxo deal in jeopardy
Bizjournals.com
Fri, 03/13/09 - 10:39 am
GSK
Synta
layoffs
elesclomol
melanoma
Synta Skin Cancer Drug Trial Halted
TheStreet.com
Thu, 02/26/09 - 07:41 pm
Synta
skin cancer
drug trials
GSK Pays Synta $10M Milestone Fee
Xconomy, MA
Sat, 02/21/09 - 12:45 pm
Merck
Synta
GlaxoSmithKline makes $10M payment to Synta
Bizjournals.com
Wed, 02/18/09 - 01:32 pm
GSK
Synta
colon cancer
elesclomol
Synta's billion-dollar drug nears end of Phase III
Fierce Biotech
Mon, 02/2/09 - 10:43 am
Synta
drug trials
cancer
elesclomol
GSK
Synta and Roche Form Discovery, Development, and Commercialization Alliance in Inflammation
Earth Times
Wed, 01/7/09 - 09:24 am
Synta
Roche
Biotech Clinical Trials to Watch in 2009
TheStreet.com
Thu, 12/18/08 - 03:43 pm
drug trials
Alnylam
Amgen
Amicus Therapeutics
Arena Pharmaceuticals
Biogen Idec
Chelsea Therapeutics
Genentech
Gilead Sciences
Human Genome Sciences
InterMune
Isis Pharmaceuticals
Neurocrine
ONYX Pharmaceuticals
Orexigen
Osiris Therapeutics
Poniard
Rigel
United Therapeutics
Synta
Synta receives $15M milestone payment from Glaxo
Yahoo
Mon, 12/15/08 - 12:17 am
Synta
GSK
cancer